CLOUDY
Nasal vaccines may remain a long-term hardliner in the fight against COVID-19 despite the “disappointing” effects of recent trials for an AstraZeneca spray, experts say.
Entering the frame in the same way as the virus, nasal vaccines aim to boost immunity in the mucous membrane lining the nose and mouth.
This is possibly due to a conflict with your security or ad-blocking software.
Upload japantimes. co. jp and piano. io to your list of sites.
If this doesn’t work or if you can’t load the domain names on your whitelist, stop by this help page.
We humbly for the inconvenience.
In an age of misinformation and too much information, quality journalism is more important than ever. By subscribing, you can help us tell the story well.
Your subscription plan allows you to comment. To be more informed, see our frequently asked questions
Japan Times Ltd. All rights reserved.